1.76 USD
-0.01 (-0.56%)
Overall NXGL gets a fundamental rating of 3 out of 10. We evaluated NXGL against 185 industry peers in the Health Care Equipment & Supplies industry. NXGL may be in some trouble as it scores bad on both profitability and health. NXGL is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
NXGL had negative earnings in the past year.
NXGL had a negative operating cash flow in the past year.
NXGL had negative earnings in each of the past 5 years.
NXGL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
NXGL has a Return On Assets (-24.78%) which is in line with its industry peers.
NXGL has a Return On Equity (-55.53%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.78% | ||
| ROE | -55.53% | ||
| ROIC | N/A |
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 38.30%, NXGL is not doing good in the industry: 68.65% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NXGL has grown nicely.
The Profit Margin and Operating Margin are not available for NXGL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.3% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
2. Health
2.1 Basic Checks
NXGL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NXGL has more shares outstanding
Compared to 5 years ago, NXGL has more shares outstanding
NXGL has a worse debt/assets ratio than last year.
2.2 Solvency
NXGL has an Altman-Z score of -0.68. This is a bad value and indicates that NXGL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.68, NXGL perfoms like the industry average, outperforming 42.16% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that NXGL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.15, NXGL perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.68 |
ROIC/WACCN/A
WACC9.71%
2.3 Liquidity
A Current Ratio of 1.69 indicates that NXGL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.69, NXGL is not doing good in the industry: 69.19% of the companies in the same industry are doing better.
A Quick Ratio of 1.08 indicates that NXGL should not have too much problems paying its short term obligations.
The Quick ratio of NXGL (1.08) is worse than 74.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
NXGL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.33%, which is quite impressive.
The Revenue has grown by 73.38% in the past year. This is a very strong growth!
Measured over the past years, NXGL shows a very strong growth in Revenue. The Revenue has been growing by 64.56% on average per year.
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%
3.2 Future
NXGL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.14% yearly.
NXGL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.74% yearly.
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NXGL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXGL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
NXGL's earnings are expected to grow with 37.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.03%
EPS Next 3Y37%
5. Dividend
5.1 Amount
No dividends for NXGL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:NXGL (1/6/2026, 8:00:02 PM)
1.76
-0.01 (-0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.77%
Inst Owner Change0%
Ins Owners13.96%
Ins Owner Change-2.42%
Market Cap14.33M
Revenue(TTM)11.66M
Net Income(TTM)-2.88M
Analysts82.86
Price Target6.12 (247.73%)
Short Float %0.08%
Short Ratio0.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.04%
Min EPS beat(2)-26.05%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-5.04%
Min EPS beat(4)-26.05%
Max EPS beat(4)11.76%
EPS beat(8)4
Avg EPS beat(8)-11.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.65%
Min Revenue beat(2)-9.08%
Max Revenue beat(2)-8.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.18%
Min Revenue beat(4)-9.08%
Max Revenue beat(4)0.94%
Revenue beat(8)4
Avg Revenue beat(8)-4.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.76 | ||
| P/tB | 4.28 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS1.43
BVpS0.64
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.78% | ||
| ROE | -55.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.3% | ||
| FCFM | N/A |
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
F-Score6
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.75% | ||
| Cap/Sales | 0.83% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | -0.68 |
F-Score6
WACC9.71%
ROIC/WACCN/A
Cap/Depr(3y)166.83%
Cap/Depr(5y)273.19%
Cap/Sales(3y)9%
Cap/Sales(5y)18.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%
EBIT growth 1Y24.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.13%
EBIT Next 3Y42.97%
EBIT Next 5Y32.41%
FCF growth 1Y35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.73%
OCF growth 3YN/A
OCF growth 5YN/A
NEXGEL INC / NXGL FAQ
What is the ChartMill fundamental rating of NEXGEL INC (NXGL) stock?
ChartMill assigns a fundamental rating of 3 / 10 to NXGL.
What is the valuation status of NEXGEL INC (NXGL) stock?
ChartMill assigns a valuation rating of 1 / 10 to NEXGEL INC (NXGL). This can be considered as Overvalued.
How profitable is NEXGEL INC (NXGL) stock?
NEXGEL INC (NXGL) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NXGL stock?
The Earnings per Share (EPS) of NEXGEL INC (NXGL) is expected to grow by 28.6% in the next year.